<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0045503</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1920</journal-id>
<journal-id journal-id-type="nlm-ta">Brain Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Brain Res.</journal-id>
<journal-title-group>
<journal-title>Brain research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-8993</issn>
<issn pub-type="epub">1872-6240</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29782851</article-id>
<article-id pub-id-type="pmc">6026032</article-id>
<article-id pub-id-type="doi">10.1016/j.brainres.2018.05.022</article-id>
<article-id pub-id-type="manuscript">NIHMS971627</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Glycosylation of Cblns attenuates their receptor binding</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Rong</surname>
<given-names>Yongqi</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bansal</surname>
<given-names>Parmil K.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wei</surname>
<given-names>Peng</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guo</surname>
<given-names>Hong</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Correia</surname>
<given-names>Kristen</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parris</surname>
<given-names>Jennifer</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morgan</surname>
<given-names>James I.</given-names>
</name>
</contrib>
<aff id="A1">Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105</aff>
</contrib-group>
<author-notes>
<corresp id="FN1">Address correspondence: James I. Morgan, Department of Developmental Neurobiology, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA, Phone: 901-595-2256, Fax: 901-595-3143, <email>jim.morgan@stjude.org</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>Conflict of interest</bold>
</p>
<p>The authors declare no conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>31</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>18</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2019</year>
</pub-date>
<volume>1694</volume>
<fpage>129</fpage>
<lpage>139</lpage>
<!--elocation-id from pubmed: 10.1016/j.brainres.2018.05.022-->
<abstract id="Abs1">
<p id="P2">Cbln1 is the prototype of a family (Cbln1–Cbln4) of secreted glycoproteins and is essential for normal synapse structure and function in cerebellum by bridging presynaptic Nrxn to postsynaptic Grid2. Here we report the effects of glycosylation on the <italic>in vitro</italic> receptor binding properties of Cblns. Cbln1, 2 and 4 harbor two N-linked glycosylation sites, one at the N-terminus is in a region implicated in Nrxn binding and the second is in the C1q domain, a region involved in Grid2 binding. Mutation (asparagine to glutamine) of the N-terminal site, increased neurexin binding whereas mutation of the C1q site markedly increased Grid2 binding. These mutations did not influence subunit composition of Cbln trimeric complexes (mediated through the C1q domain) nor their assembly into hexamers (mediated by the N-terminal region). Therefore, glycosylation likely masks the receptor binding interfaces of Cblns. As Cbln4 has undetectable Grid2 binding <italic>in vitro</italic> we assessed whether transgenic expression of wild type Cbln4 or its glycosylation mutants rescued the Cbln1-null phenotype <italic>in vivo</italic>. Cbln4 partially rescued and both glycosylation mutants completely rescued ataxia in cbln1-null mice. Thus Cbln4 has intrinsic Grid2 binding that is attenuated by glycosylation, and glycosylation mutants exhibit gain of function <italic>in vivo</italic>.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>Graphical Abstract</title>
<p id="P3">
<graphic orientation="portrait" position="anchor" xlink:href="nihms971627u1.jpg"></graphic></p>
</abstract>
<kwd-group>
<kwd>glycosylation</kwd>
<kwd>transgenic</kwd>
<kwd>locomotor activity</kwd>
<kwd>S4 domain</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>